Inhalatie Medicatie Instructie School IMIS
Stichting IMIS is a Dutch non-profit foundation that delivers accredited training to healthcare professionals on correct inhalation medication techniques for asthma and COPD patients, supported by a national 12-province trainer network and a library of 50-plus inhaler instruction cards.
- Company typePrivate
- Founded2008
- HeadquartersWinsum, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Inhalatie Medicatie Instructie School IMIS does
Stichting Inhalatie Medicatie Instructie School (IMIS) is a Dutch non-profit foundation founded in 2008 and headquartered in Winsum, Netherlands. Its primary function is to train healthcare professionals — including general practitioners, practice assistants, pharmacists, pharmacy assistants, hospital pharmacists, pulmonary specialists, lung function analysts and nurses — in evidence-based inhalation medication instruction techniques for patients with chronic respiratory conditions such as asthma and COPD. The foundation states it operates independently from pharmaceutical companies, providing scientifically grounded training. It is structurally embedded within Inhalatie Instituut Nederland (IIN), which functions as its parent body.
IMIS's core product is its accredited training portfolio, delivered through a network of certified trainers distributed across all 12 Dutch provinces. Training is accredited by multiple professional associations including V&V, Verpleegkundig Specialisten Register, NVDA, NVLA, NVvPO, OA, ZA, NVFZ and Cluster 1. The foundation also maintains a content library of downloadable patient instruction cards (Patiëntenkaarten) covering more than 50 inhaler types and brands, plus a Kennisbank knowledge base with resistance charts, selection schemes and educational materials. It collaborates with Longalliantie Nederland (LAN) on the Zorgpad Inhalatiemedicatie care pathway.
The business model is professional services: training sessions are delivered to healthcare organizations on request, with no publicly disclosed pricing. There is no software platform, no app, no API, and no AI component. Headcount is reported at 1-10 employees, consistent with a lean non-profit operating model, and revenue is not publicly disclosed.
Inhalatie Medicatie Instructie School IMIS firmographics
Firmographics- Name
- Inhalatie Medicatie Instructie School IMIS
- Legal name
- Stichting Inhalatie Medicatie Instructie School
- Website
- https://stichtingimis.nl
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Stichting IMIS is a Dutch non-profit foundation that delivers accredited training to healthcare professionals on correct inhalation medication techniques for asthma and COPD patients, supported by a national 12-province trainer network and a library of 50-plus inhaler instruction cards.
- Ownership category
- akta.pro rank
Inhalatie Medicatie Instructie School IMIS industry classification
Industry- Product category
- Healthcare Professional Training
- NAICS
- Educational Support Services (611710), Professional and Management Development Training (611430)
- SIC
- Services-Educational Services (8200), Services-Health Services (8000)
- akta.pro primary industry
- Healthcare & Life Sciences (EDAAAPAA)
Keywords
Where Inhalatie Medicatie Instructie School IMIS is headquartered
LocationHeadquarters
- HQ city
- Winsum
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Inhalatie Medicatie Instructie School IMIS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Training services: The foundation generates revenue through organizing and delivering training sessions for healthcare professionals on inhalation medication techniques. Organizations can request training through the training organizer page on the website.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Inhalatie Medicatie Instructie School IMIS product offering
Product offeringCore offering
Stichting IMIS is a Dutch non-profit foundation that organizes and delivers accredited training programs teaching healthcare professionals how to instruct patients in correct inhalation medication technique. Training is based on the latest scientific insights and is independent of pharmaceutical companies. The foundation complements training delivery with a downloadable library of patient instruction cards (Patiëntenkaarten) for more than 50 inhaler types and an online Kennisbank (knowledge bank) with practical tools and educational resources.
Product overview
Stichting IMIS offers a portfolio of healthcare training products and educational resources focused on inhalation medication instruction. The core offering consists of accredited training programs for healthcare professionals on inhalation techniques based on scientific insights, independent of pharmaceutical companies. This is complemented by a library of downloadable patient instruction cards (Patiëntenkaarten) covering dozens of inhaler types, a knowledge bank with tools and educational materials, and a network of certified trainers distributed across the Netherlands. The organization is part of Inhalatie Instituut Nederland (IIN) and does not provide software products or AI-powered solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- IMIS Training Programs
Companies that use Inhalatie Medicatie Instructie School IMIS
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Inhalatie Medicatie Instructie School IMIS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Inhalatie Medicatie Instructie School IMIS partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Inhalatie Instituut Nederland (IIN)coreThe foundation is an integral part of Inhalatie Instituut Nederland (IIN), which serves as the parent organization overseeing the foundation's activities in the field of inhalation medication instruction.
- Longalliantie Nederland (LAN)coreCollaboration on the 'Zorgpad Inhalatiemedicatie' (Care Pathway Inhalation Medication), a policy document describing the collaborative care pathway from diagnosis to treatment plan and medication guidance for patients with respiratory conditions.
Scale indicators2 records
Recent moves5 records
Expansion highlights3 records
Inhalatie Medicatie Instructie School IMIS competitors and assessment
Company assessmentOthers
- Longfonds (Dutch Lung Foundation): The Netherlands' primary lung-health charity, funding research and running patient and professional education programs on asthma, COPD, and other respiratory conditions. It addresses the same Dutch respiratory-care market and audience that IMIS trains.
- Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose (NVALT): Dutch professional society for lung physicians and tuberculosis specialists. NVALT provides specialty medical education and clinical guidance in respiratory care, overlapping with IMIS's mission of training healthcare professionals in inhalation technique.
- Longalliantie Nederland (LAN): Dutch national alliance focused on respiratory care policy and care pathways. LAN co-developed the 'Zorgpad Inhalatiemedicatie' with IMIS and operates in the same Dutch respiratory-care ecosystem, addressing similar audiences of healthcare professionals and patients.
- Inhalatie Instituut Nederland (IIN): Parent organization of IMIS. IIN is the Dutch umbrella institute overseeing inhalation medication education and research, making it the closest institutional counterpart and the natural vehicle for any scale-up of IMIS's activities.
- Global Initiative for Asthma (GINA): International collaboration producing widely used evidence-based asthma management strategies and educational resources for healthcare professionals. Relevant as a standards-setting body whose guidelines underpin inhalation-technique training like IMIS's.
Regional players
- Asthma + Lung UK: UK respiratory charity delivering patient and professional education on inhaler technique and respiratory disease self-management. Operates in a comparable niche (inhaler instruction) in a different national market, making it a useful cross-border functional comparable.
- COPD Foundation: US not-for-profit focused on COPD education, research, and patient/provider resources. Operates in the same chronic respiratory disease space as IMIS, including inhaler-technique and self-management education, but in a different geography.
Broad incumbents
- European Respiratory Society (ERS): International professional society providing continuing medical education, clinical guidelines, and training resources in respiratory medicine across Europe. Comparable to IMIS in delivering professional respiratory education, but operating at pan-European scale and through physician-focused channels.
- American College of Chest Physicians (CHEST): Large US-based professional medical society offering accredited continuing education, simulation training, and clinical resources for pulmonologists and related providers. Comparable in delivering accredited respiratory professional education, but at much greater scale and broader scope.
Emerging players
- Vitalograph: Manufacturer of respiratory diagnostic and training devices, including the In-Check-DIAL used in IMIS training curricula. Comparable as a provider of both respiratory devices and the educational/training materials that accompany them, intersecting with IMIS's core activity.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Inhalatie Medicatie Instructie School IMIS social profiles
Digital presenceInhalatie Medicatie Instructie School IMIS financial estimates
Financial estimateRevenue estimate
Valuation estimate
Inhalatie Medicatie Instructie School IMIS leadership team
Management profileNumber of profiles
Inhalatie Medicatie Instructie School IMIS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Inhalatie Medicatie Instructie School IMIS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Inhalatie Medicatie Instructie School IMIS
What does Inhalatie Medicatie Instructie School IMIS do?
Stichting IMIS is a Dutch non-profit foundation that organizes and delivers accredited training programs teaching healthcare professionals how to instruct patients in correct inhalation medication technique. Training is based on the latest scientific insights and is independent of pharmaceutical companies. The foundation complements training delivery with a downloadable library of patient instruction cards (Patiëntenkaarten) for more than 50 inhaler types and an online Kennisbank (knowledge bank) with practical tools and educational resources.
Is Inhalatie Medicatie Instructie School IMIS a public or private company?
Inhalatie Medicatie Instructie School IMIS is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Inhalatie Medicatie Instructie School IMIS founded?
Inhalatie Medicatie Instructie School IMIS was founded in 2008. It employs 1 to 10 people.
Where is Inhalatie Medicatie Instructie School IMIS based?
Inhalatie Medicatie Instructie School IMIS is headquartered in Winsum, Netherlands, in the Europe region.
How does Inhalatie Medicatie Instructie School IMIS make money?
One revenue line is on record: training services.
Who are Inhalatie Medicatie Instructie School IMIS's main competitors?
Others on record are Longfonds (Dutch Lung Foundation), Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose (NVALT), Longalliantie Nederland (LAN), Inhalatie Instituut Nederland (IIN) and Global Initiative for Asthma (GINA). Regional players are Asthma + Lung UK and COPD Foundation. Broad incumbents are European Respiratory Society (ERS) and American College of Chest Physicians (CHEST). Vitalograph is listed as an emerging player.
Does Inhalatie Medicatie Instructie School IMIS have an API?
No public API is recorded for Inhalatie Medicatie Instructie School IMIS.
What industry is Inhalatie Medicatie Instructie School IMIS in?
Inhalatie Medicatie Instructie School IMIS's product category is Healthcare Professional Training. Its primary akta.pro industry code is EDAAAPAA, Healthcare & Life Sciences. Its NAICS code is 611710 and its SIC code is 8200.